Get the Stockscreener App
25.80
3.98%
-1.07
After Hours:
27.28
1.48
+5.74%
Neurogene Inc Stock (NGNE) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 |
| Period Length | 3 Months | 3 Months |
| Revenues |
100.00%
-
|
-2.968 |
Operating Expenses
|
40.97%
18.78
|
31.82 |
| Interest Income/Expense |
0.003
|
- |
| Operating Income/Loss |
40.97%
-18.78
|
-31.82 |
| Income/Loss From Continuing Operations Before Tax |
56.93%
-16.92
|
-39.28 |
| Income/Loss From Continuing Operations After Tax |
9.15%
-16.92
|
-15.50 |
|
Net Income/Loss
|
9.15%
-16.92
|
-15.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
16.90
|
- |
| Diluted Average Shares |
16.90
|
- |
| Basic Earnings Per Share |
-1.00
|
- |
| Diluted Earnings Per Share |
-1.00
|
- |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):